Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 55.12%
March 31, 2026 55.57%
December 31, 2025 57.12%
September 30, 2025 46.65%
June 30, 2025 52.62%
March 31, 2025 52.56%
December 31, 2024 53.14%
September 30, 2024 53.70%
June 30, 2024 52.35%
March 31, 2024 51.98%
December 31, 2023 51.50%
September 30, 2023 51.66%
June 30, 2023 50.45%
March 31, 2023 49.22%
December 31, 2022 53.10%
September 30, 2022 50.96%
June 30, 2022 51.13%
March 31, 2022 52.44%
December 31, 2021 56.85%
September 30, 2021 53.89%
June 30, 2021 52.43%
March 31, 2021 51.91%
December 31, 2020 50.86%
September 30, 2020 53.15%
June 30, 2020 48.02%
Date Value
March 31, 2020 52.69%
December 31, 2019 50.54%
September 30, 2019 52.28%
June 30, 2019 51.30%
March 31, 2019 55.56%
December 31, 2018 54.82%
September 30, 2018 54.34%
June 30, 2018 54.28%
March 31, 2018 54.22%
December 31, 2017 56.34%
September 30, 2017 54.63%
June 30, 2017 53.24%
March 31, 2017 54.16%
December 31, 2016 52.41%
September 30, 2016 54.77%
June 30, 2016 55.37%
March 31, 2016 54.42%
December 31, 2015 55.06%
September 30, 2015 56.07%
June 30, 2015 52.50%
March 31, 2015 53.17%
December 31, 2014 53.94%
September 30, 2014 55.60%
June 30, 2014 50.59%
March 31, 2014 56.90%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 65.92%
Stryker Corp. 66.14%
Alphatec Holdings, Inc. 62.90%
Baxter International, Inc. 33.55%
Integra LifeSciences Holdings Corp. 54.87%